...
首页> 外文期刊>Iranian red crescent medical journal >Fluid Resuscitation, Which Fluid is the Best for Each Patient? A Systematic Review and Meta Analysis
【24h】

Fluid Resuscitation, Which Fluid is the Best for Each Patient? A Systematic Review and Meta Analysis

机译:液体复苏,哪种液体最适合每个患者?系统评价和元分析

获取原文

摘要

Context: Fluid therapy is the basis of resuscitation; however, there has been a heated debate on the choice of appropriate fluid. This study mainly aimed to determine which fluid is correlated with a decline in mortality rate and can be the most suitable choice for each group of patients. Evidence Acquisition: We conducted a systematic search on Google Scholar, Web of Science, Scopus, BMJ Journals, Thieme, Path Consult, BIDS Index, Embase, Medline, and Cochrane Controlled Trials up to April 2016. The relevant studies were those that provided a comparison between the effects of different fluids on the mortality rate of patients. Two independent authors participated in the evaluating methodological quality, selecting eligible studies, and extracting the relevant data from the studies. Results: We selected 26 out of 2724 potential randomized controlled trials (RCTs) from the databases for both quantitative and qualitative analyses resulting in a total of 22882 patients receiving either colloid or crystalloid fluids. The approximated pooled Relative risk (RR) for the death of patients who had been resuscitated with crystalloid fluid therapy rather than colloid fluid therapy was 1.008. This meta-analysis illustrated that there was a decline in the mortality rate with borderline significance in both traumatic and hypovolemic patients through utilizing colloid fluids. The mortality reduced more by using dextran and albumin than using crystalloid fluids. Conclusions: The results of this meta-analysis show that colloid fluids can increase the successful resuscitation rate compared to crystalloid fluids especially in traumatic and hypovolemic patients.Some of the colloids like albumin and dextran have a positive effect on reducing the mortality rate but others like Hetastarch (HES) increase the mortality rate compared to normal saline (NS). Keywords: Resuscitation;
机译:背景:液体疗法是复苏的基础;但是,关于选择合适的流体一直存在激烈的争论。这项研究的主要目的是确定哪种液体与死亡率下降相关,并且可以成为每组患者的最合适选择。证据收集:截至2016年4月,我们对Google学术搜索,Web of Science,Scopus,BMJ Journals,Thieme,Path Consult,BIDS Index,Embase,Medline和Cochrane对照试验进行了系统的搜索。相关的研究提供了比较不同液体对患者死亡率的影响。两名独立作者参加了方法学质量评估,选择合格的研究并从研究中提取相关数据。结果:我们从数据库中选择了2724项潜在的随机对照试验(RCT)中的26项进行了定量和定性分析,结果共有22882例患者接受了胶体液或晶体液。用晶体液体疗法而非胶体液体疗法复苏的患者死亡的总合并相对危险度(RR)为1.008。这项荟萃分析表明,通过使用胶体液,创伤患者和低血容量患者的死亡率都有临界意义的下降。与使用结晶液相比,使用右旋糖酐和白蛋白可降低死亡率。结论:这项荟萃分析的结果表明,与晶体液相比,胶体液可以提高成功的复苏率,尤其是在创伤和低血容量患者中。 Hetastarch(HES)与生理盐水(NS)相比增加死亡率。关键字:复苏;

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号